Table 3.
Characteristic | Value |
---|---|
Remission at 1 year after end of treatment | 76 (82) |
Death | 7 (8) |
During treatment period | 4 (4) |
After end of treatment | 3 (3) |
Causes of death | |
Death by infection | 1 (1) |
Death by cancer | 3 (3) |
Death by acute respiratory distress syndrome caused by severe pneumonia | 2 (2) |
Death by suicide | 1 (1) |
Unfavourable clinical outcomes | 16 (17) |
Death by infection | 1 (1) |
Failure during treatment | 8 (9) |
Median time to failure | 141 days |
Evolution | |
Remission after further ATB | 1 (1) |
Failure after further treatment | 4 (4) |
Wound care only | 2 (2) |
Wound care with suppressive antibiotic therapy | 2 (2) |
Remission after osteosynthesis removal and antibiotic therapy | 1 (1) |
Amputation | 2 (2) |
Relapse | 7 (8) |
Median time to relapse (after end of treatment) | 218 days |
Evolution (after further treatment) | |
Remission | 2 (2) |
Amputation | 5 (5) |
Amputation | 19 (20) |
Median time to amputation (from date of infection) | 447 days |
Type of infection | |
Diabetic foot | 11 (12) |
Ischemic foot | 1 (1) |
Chronic wound of foot | 1 (1) |
Chronic osteitis | 5 (5) |
Joint prosthesis infection | 1 (1) |
Delay of amputation | |
Before starting antibiotic treatmenta | 3 (3) |
Diabetic foot | 3 (3) |
During antibiotic treatment | 10 (11) |
Neoplastic transformation | 1 (1) |
Ischemic foot | 1 (1) |
Diabetic foot | 5 (5) |
Chronic osteitis | 2 (2) |
Joint prosthesis infection | 1 (1) |
Treatment failure | 0 |
After end of antibiotic treatmenta | 7 (8) |
Neoplastic transformation | 0 |
Ischemic foot | 0 |
Diabetic foot | 4 (4) |
Chronic osteitis | 3 (3) |
Joint prosthesis infection | 0 |
Failure to treatment | 2 (2) |
Relapse | 5 (5) |
Reason for amputation | |
Treatment failure | 2 (2) |
Relapse | 6 (6) |
Other | 11 (12) |
Neoplastic transformation of foot osteitis | 1 (1) |
Ischemic foot | 1 (1) |
Diabetic foot | 6 (6) |
Chronic osteitis | 2 (2) |
Joint prosthesis infection | 1 (1) |
Data are presented as n (%) unless otherwise indicated.
Unfavourable clinical outcome was included in cases of treatment failure and relapse.